SOTIO Biotech is a clinical-stage immuno-oncology company based in Boston, MA. They are focused on developing potent immunotherapies for patients with cancer, with a pipeline that includes both internally developed and in-licensed candidates for the treatment of various solid tumor types. Their goal is to advance safer and more effective immunotherapies through clinical development.
SOTIO Biotech aims to shape the future of cancer immunotherapies by translating compelling science into patient benefit. They are committed to developing immuno-oncology therapies that improve outcomes for patients with solid tumors, utilizing platforms such as immunocytokines, BOXR cell therapy, and antibody-drug conjugates. With a strong emphasis on research and development, SOTIO Biotech is dedicated to bringing innovative treatments to the forefront of cancer care.
Generated from the website